Literature DB >> 26298309

Disrupted glutamate-glutamine cycle in acute encephalopathy with biphasic seizures and late reduced diffusion.

Jun-Ichi Takanashi1, Masashi Mizuguchi2, Masaru Terai3, A James Barkovich4.   

Abstract

INTRODUCTION: Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is the most common subtype of infectious pediatric encephalopathy in Japan. It is sometimes difficult to make an early diagnosis of AESD; excitotoxicity is postulated to be the pathogenesis based on elevated glutamine (Gln) and glutamate (Glu) complex (Glx = Glu + Gln) observed on MR spectroscopy. It is uncertain whether Gln or Glu contributes to the elevated Glx, or whether MR spectroscopy is useful for an early diagnosis.
METHODS: Five Japanese patients with AESD (three boys and two girls, 1 year of age) were enrolled in this study. MR spectroscopy was acquired from the frontal white matter (repetition time (TR) of 5000 ms, echo time (TE) of 30 ms) with a 1.5- or 3.0-T scanner. MR spectroscopy was performed four times for two patients, three times for one patient, and two times for two patients. Quantification of Glu and Gln was performed using LCModel.
RESULTS: Glu was elevated in three of four studies on days 1-4 and became normal or low afterward. Gln was normal in three studies on days 1-2, elevated in all seven studies on days 4-12, and became normal or low afterward.
CONCLUSION: These findings suggest that MR spectroscopy may be useful for an early diagnosis. Acute Glu elevation changes to subacute Gln elevation, suggesting that a disrupted Glu-Gln cycle may play an important role.

Entities:  

Keywords:  Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD); Encephalopathy; Glutamate; Glutamine; MR spectroscopy

Mesh:

Substances:

Year:  2015        PMID: 26298309     DOI: 10.1007/s00234-015-1573-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  21 in total

Review 1.  Diffusion-weighted imaging of acute excitotoxic brain injury.

Authors:  Toshio Moritani; Wendy R K Smoker; Yutaka Sato; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

2.  Diffusion MRI abnormalities after prolonged febrile seizures with encephalopathy.

Authors:  J Takanashi; H Oba; A J Barkovich; H Tada; Y Tanabe; H Yamanouchi; S Fujimoto; M Kato; M Kawatani; A Sudo; H Ozawa; T Okanishi; M Ishitobi; Y Maegaki; Y Koyasu
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

3.  Proton MR spectroscopy-detectable major neurotransmitters of the brain: biology and possible clinical applications.

Authors:  N Agarwal; P F Renshaw
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-29       Impact factor: 3.825

4.  Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes.

Authors:  Ai Hoshino; Makiko Saitoh; Akira Oka; Akihisa Okumura; Masaya Kubota; Yoshiaki Saito; Jun-Ichi Takanashi; Shinichi Hirose; Takanori Yamagata; Hideo Yamanouchi; Masashi Mizuguchi
Journal:  Brain Dev       Date:  2011-09-15       Impact factor: 1.961

Review 5.  Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature.

Authors:  Andrea E Spencer; Mai Uchida; Tara Kenworthy; Christopher J Keary; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2014-11       Impact factor: 4.384

6.  Serum and CSF biomarkers in acute pediatric neurological disorders.

Authors:  Takashi Shiihara; Taeko Miyake; Sakiko Izumi; Susumu Sugihara; Mio Watanabe; Jun-ichi Takanashi; Masaya Kubota; Mitsuhiro Kato
Journal:  Brain Dev       Date:  2013-07-11       Impact factor: 1.961

7.  Excitotoxicity in acute encephalopathy with biphasic seizures and late reduced diffusion.

Authors:  J Takanashi; H Tada; H Terada; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-13       Impact factor: 3.825

8.  Extraordinary changes in excitatory amino acid levels in cerebrospinal fluid of influenza-associated encephalopathy of children.

Authors:  Hisashi Kawashima; Tsuneo Morishima; Takehiro Togashi; Shunpei Yokota; Gaku Yamanaka; Hiroaki Ioi; Yasuyo Kashiwagi; Kouji Takekuma; Akinori Hoshika; Yasuo Watanabe
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

Review 9.  Two newly proposed infectious encephalitis/encephalopathy syndromes.

Authors:  Jun-ichi Takanashi
Journal:  Brain Dev       Date:  2009-03-31       Impact factor: 1.961

Review 10.  Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning.

Authors:  George Trendelenburg; Ulrich Dirnagl
Journal:  Glia       Date:  2005-06       Impact factor: 8.073

View more
  5 in total

1.  An infantile traumatic brain injury with a bright tree appearance detected before the late seizure.

Authors:  Naoki Kaneko; Hideo Nishizawa; Junichi Fujimoto; Taikan Nanao; Yasuhiro Kimura; Gen Owada
Journal:  Childs Nerv Syst       Date:  2022-06-23       Impact factor: 1.475

2.  In vitro neuroprotective effects of ciliary neurotrophic factor on dorsal root ganglion neurons with glutamate-induced neurotoxicity.

Authors:  Shu-Yun Wen; Ai-Min Li; Kuan-Qing Mi; Rui-Zheng Wang; Hao Li; Hua-Xiang Liu; Yi Xing
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

3.  GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion.

Authors:  Mariko Kasai; Yosuke Omae; Yosuke Kawai; Akiko Shibata; Ai Hoshino; Masashi Mizuguchi; Katsushi Tokunaga
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

Review 4.  A Comprehensive Review of Pediatric Acute Encephalopathy.

Authors:  George Imataka; Shigeko Kuwashima; Shigemi Yoshihara
Journal:  J Clin Med       Date:  2022-10-07       Impact factor: 4.964

5.  Acute encephalopathy with biphasic seizures and late reduced diffusion: A case report.

Authors:  Yan-Li Ma; Kai-Li Xu; Guo-Hong Chen; Li Wang; Yuan Wang; Zhi-Peng Jin
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.